Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review
2017
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Rationally Designed Integrin β3 Mutants Stabilized in the High Affinity Conformation
2008 StandoutNobel
Epidemiology and causes of preterm birth
2008 Standout
Extracorporeal shockwave therapy for the treatment of lower limb intermittent claudication: study protocol for a randomised controlled trial (the SHOCKWAVE 1 trial)
2017 StandoutNobel
Platelet Aggregation in Washed Suspensions
1971
Flavonoids as anti-inflammatory agents
2010 Standout
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor
2001
Oxidative stress, aging, and diseases
2018 Standout
Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/β-lactone is not a specific inhibitor of the proteasome
2000 StandoutNobel
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
2005 StandoutNobel
Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature
2008
Platelet functions and clinical effects in acute myelogenous leukemia
2007
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
2008 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Platelet activation, coagulation activation and C‐reactive protein in simultaneous samples from the vascular access and peripheral veins of haemodialysis patients
2011
HIV infection, HAART, and endothelial adhesion molecules: current perspectives
2004
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Venous thromboembolism syndrome in gynecological cancer
2006
Platelets and acute cerebral infarction
2012 StandoutNobel
Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease
2001
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
High detection rates of antithrombin deficiency and antiphospholipid syndrome in outpatients aged over 50 years using the standardized protocol for thrombophilia screening
2019
Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)
2009 Standout
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics
2013
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients
2003
Biological roles of glycans
2016 Standout
Nutrition and platelet function in atherogenesis
1987
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians
2016
The pathophysiology of cigarette smoking and cardiovascular disease
2004 Standout
Age-related macular degeneration
2018 Standout
Prevention of Venous Thromboembolism
2004 Standout
Platelet‐rich plasma and platelet gel preparation using Plateltex®
2008
The adhesion molecule P-selectin and cardiovascular disease
2003
Prevention of Venous Thromboembolism
2008 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
2020 Standout
Chemotherapy-induced thrombosis
2006
Effect of Troglitazone on Fibrinolysis and Activated Coagulation in Patients With Non–Insulin-Dependent Diabetes Mellitus
1998
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Peripheral vascular disease and Virchow's triad for thrombogenesis
2002
Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta‐Analysis
2019
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Interactions of Prostaglandin H2 and Thromboxane A2 with Human Serum Albumin
1980 StandoutNobel
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Impaired Flow-Mediated Vasodilation, Carotid Artery Intima-Media Thickening, and Elevated Endothelial Plasma Markers in Obese Children: The Impact of Cardiovascular Risk Factors
2006
Prostacyclin and Blood Coagulation
1981 StandoutNobel
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Thromboxane Synthesis and the Platelet Release Reaction in Bernard‐Soulier Syndrome, Thrombasthenia Glanzmann and Hermansky‐Pudlak Syndrome
1977 StandoutNobel
Platelets, Thrombosis and Drugs
1975
Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes
1975 Nature
Soluble P-Selectin and the Risk of Future Cardiovascular Events
2001
von Willebrand Factor
1998
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
1976 StandoutNobel
Mechanisms of platelet aggregation by viridans group streptococci
1987
Isolation, crystallization, and primary amino acid sequence of human platelet factor 4.
1977
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
2000 Standout
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Inflammation and Atherosclerosis
2002 Standout
Platinum-Based Compounds and Risk for Cardiovascular Toxicity in the Elderly: Role of the Antioxidants in Chemoprevention
2011
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
1983
High-Density Lipoproteins and Endothelial Function
2001
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Lifetime Smoking Exposure Affects the Association of C-Reactive Protein with Cardiovascular Disease Risk Factors and Subclinical Disease in Healthy Elderly Subjects
1997
COAGULATION DISORDERS IN CANCER
1996
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.
1983 Standout
Acquired Platelet Dysfunction in Patients with Uremia
1990
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Vascular toxicity associated with antineoplastic agents.
1986
Lysosomal Consept of Platelet Secretion ‐ Revisited
1989
Markers of Thrombin and Platelet Activity in Patients With Atrial Fibrillation
1999
Effect on platelet aggregation of oral administration of 10 non‐steroidal analgesics to humans
1984
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Soluble Adhesion Molecules Reflect Endothelial Cell Activation in Ischemic Stroke and in Carotid Atherosclerosis
1997
Elevated Plasma Vascular Endothelial Cell Growth Factor and Thrombomodulin in Juvenile Diabetic Patients
1999
Erythropoietin or darbepoetin for patients with cancer
2012
Biochemical and inflammatory changes in the exercising claudicant
1998
Biological Profiles in Subjects With Recurrent Acute Coronary Events Compared With Subjects With Long-Standing Stable Angina
2001
The Vascular Endothelium and Human Diseases
2013 Standout
Antiinflammatory Properties of HDL
2004 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction
1999 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of Peter Kubisz being referenced
Circulating vascular endothelial growth factor in the normo- and/or microalbuminuric patients with type 2 diabetes mellitus
2009
Erythropoietin and granulocyte colony-stimulating factor increase plasminogen activator inhibitor-1 release in HUVEC culture
2002
ENDOTHELIAL MARKERS IN DIABETES MELLITUS
1997
Recombinant Activated Factor VII in Patients at High Risk of Bleeding
2004
Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow‐up study
2018
Platelet reactivity: a contribution to age dependence studies.
1988
Influence of Cytotoxic Drugs on Platelet Functions and Coagulation in vitro.
1977
Influence of Mithramycin on Some Platelet Functions <i>in vitro</i>
1980
Influence of cis-platinum on some platelet functions in vitro.
1983
Soluble P-Selectin During a Single Hemodialysis Session in Patients With Chronic Renal Failure and Erythropoietin Treatment
2007
Platelet acid phosphatase availability.
1970
Thrombocytopathia with Abnormalities in Platelet Release Reaction
1973
Acid Phosphatases and Platelet Factor 3
1968
Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
2009
Factor V Leiden and Prothrombin G20210A Mutations and the Risk of Atherothrombotic Events in Systemic Lupus Erythematosus
2004
Reptilase clot retraction test. (Its cofactors and relation to other platelet functions).
1975
Influence of Cytostatics on Some Platelet Functions <i>in vitro</i>
1977
Demonstration of a Plasmatic Cofactor Different from Fibrinogen Necessary for Platelet Release by ADP and Adrenaline
1970
Acid Phosphatases of Platelets during Coagulation and Storage of Blood
1968
von Willebrand Factor, Soluble P-Selectin, Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Atherosclerosis
1995
Relationship between platelet aggregation and plasma β-thromboglobulin levels in arteriovascular and renal diseases
1985
On the Mechanism by which Bovine Fibrinogen Induces the Release and Availability Reaction of Human Blood Platelets
1973
Investigations on Platelet Function in Diabetes mellitus
1984
Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences
2016
New Data on Glanzmann's Thrombasthenia
1971